|
1
|
Dong X and Mumper RJ: Nanomedicinal
strategies to treat multidrug-resistant tumors: Current progress.
Nanomedicine (Lond). 5:597–615. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Bono JS and Ashworth A: Translating
cancer research into targeted therapeutics. Nature. 467:543–549.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Widder KJ, Senyel AE and Scarpelli GD:
Magnetic microshperes: A model system for site specific drug
delivery in vivo. Proc Soc Exp Biol Med. 158:pp. 141–146. 1978;
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang X, Chen Y, Yuan R, Chen G, Blanco E,
Gao J and Shuai X: Folate-encoded and Fe3O4-loaded polymeric
micelles for dual targeting of cancer cells. Polymer. 49:3477–3485.
2008. View Article : Google Scholar
|
|
5
|
Kim KY: Nanotechnology platforms and
physiological challenges for cancer therapeutics. Nanomedicine.
3:103–110. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gao J and Xu B: Applications of
nanomaterials inside cells. Nano Today. 4:37–51. 2009. View Article : Google Scholar
|
|
7
|
Berry CC, Wells S, Charles S and Curtis
AS: Dextran and albumin derivatised iron oxide nanoparticles:
Influence on fibroblasts in vitro. Biomaterials. 24:4551–4557.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Perets A, Baruch Y, Weisbuch F, Shoshany
G, Neufeld G and Cohen S: Enhancing the vascularization of
three-dimensional porous alginate scaffolds by incorporating
controlled release basic fibroblast growth factor microspheres. J
Biomed Mater Res A. 65:489–497. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu ZL, You CL, Wang B, Lin JH, Hu XF,
Shan XY, Wang MS, Zheng HB and Zhang YD: Construction of Ang2-siRNA
chitosan magnetic nanoparticles and the effect on Ang2 gene
expression in human malignant melanoma cells. Oncol Lett.
11:3992–3998. 2016.PubMed/NCBI
|
|
10
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Estimating the world cancer burden: Globocan 2000. Int J Cancer.
94:153–156. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Venza M, Visalli M, Beninati C, De Gaetano
GV, Teti D and Venza I: Cellular mechanisms of oxidative stress and
action in melanoma. Oxid Med Cell Longev. 2015:4817822015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Häfeli UO: Magnetically modulated
therapeutic systems. Int J Pharm. 277:19–24. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee H, Yu MK, Park S, Moon S, Min JJ,
Jeong YY, Kang HW and Jon S: Thermally cross-linked
superparamagnetic iron oxide nanoparticles: Synthesis and
application as a dual imaging probe for cancer in vivo. J Am Chem
Soc. 129:12739–12745. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Unger E, Porter T, Lindner J and Grayburn
P: Cardiovascular drug delivery with ultrasound and microbubbles.
Adv Drug Deliv Rev. 72:110–126. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sehrig F Zeinali, Majidi S, Nikzamir N,
Nikzamir N, Nikzamir M and Akbarzadeh A: Magnetic nanoparticles as
potential candidates for biomedical and biological applications.
Artif Cells Nanomed Biotechnol. 44:918–927. 2016.PubMed/NCBI
|
|
16
|
Ishii T, Okahata Y and Sato T: Mechanism
of cell transfection with plasmid/chitosan complexes. Biochim
Biophys Acta. 1514:51–64. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu B, Tai HC, Xue W, Lee LJ and Lee RJ:
Receptor-targeted nanocarriers for therapeutic delivery to cancer.
Mol Membr Biol. 27:286–298. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Torchilin VP: Passive and active drug
targeting: Drug delivery to tumors as an example. Handb Exp
Pharmacol. 1–53. 2010.PubMed/NCBI
|
|
19
|
Wang HH, Wang YX, Leung KC, Au DW, Xuan S,
Chak CP, Lee SK, Sheng H, Zhang G, Qin L, et al: Durable
mesenchymal stem cell labelling by using polyhedral
superparamagnetic iron oxide nanoparticles. Chemistry.
15:12417–12425. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hsieh WJ, Liang CJ, Chieh JJ, Wang SH, Lai
IR, Chen JH, Chang FH, Tseng WK, Yang SY, Wu CC and Chen YL: In
vivo tumor targeting and imaging with anti-vascular endothelial
growth factor antibody-conjugated dextran-coated iron oxide
nanoparticles. Int J Nanomedicine. 7:2833–2842. 2012.PubMed/NCBI
|
|
21
|
Zhou X, Zhang M, Yung B, Li H, Zhou C, Lee
LJ and Lee RJ: Lactosylated liposomes for targeted delivery of
doxorubicin to hepatocellular carcinoma. Int J Nanomedicine.
7:5465–5474. 2012.PubMed/NCBI
|
|
22
|
Maruyama K: Intracelluar targeting
delivery of liposomal drugs to solid tumors based on EPR effect.
Adv Drug Deliv Rev. 63:161–169. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Payne SJ and Jones L: Influence of the
tumor microenvironment on angiogenesis. Future Oncol. 7:395–408.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Danquah MK, Zhang XA and Mahtao RI:
Extravasation of polymeric nanomedicines across tumor vasculature.
Adv Drug Deliv Rev. 63:623–639. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Neuberger T, Schöpf B, Hofmann H, Hofmann
M and Rechenberg BV: Superparamagnetic nanoparticles for biomedical
applications: Possibilities and limitations of a new drug delivery
system. J Magn Magn Mater. 293:483–496. 2005. View Article : Google Scholar
|
|
26
|
Lammers T, Kiessling F, Hennink WE and
Storm G: Drug targeting to tumors: Principles, pitfalls and (pre-)
clinical progress. J Control Release. 161:175–187. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yi GQ, Gu B and Chen LK: The safety and
efficacy of magnetic nano-iron hyperthermia therapy on rat brain
glioma. Tumour Biol. 35:2445–2449. 2014. View Article : Google Scholar : PubMed/NCBI
|
